CytoDyn Inc.
CYDY
$0.35
$0.038.84%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.69M | -22.61M | -5.54M | -5.96M | -4.76M |
| Total Depreciation and Amortization | 4.00K | 5.00K | 4.00K | 4.00K | 5.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 59.00K | 110.00K |
| Total Other Non-Cash Items | 2.07M | 483.00K | 179.00K | 599.00K | 13.00K |
| Change in Net Operating Assets | -2.91M | 17.77M | 2.91M | -369.00K | -326.00K |
| Cash from Operations | -5.52M | -4.35M | -2.45M | -5.66M | -4.96M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -142.00K | 0.00 | 0.00 |
| Issuance of Common Stock | 15.32M | 0.00 | 21.00K | 1.17M | 21.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 874.00K | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 16.19M | 0.00 | -121.00K | 1.17M | 21.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.67M | -4.35M | -2.57M | -4.50M | -4.94M |